Organon & Co.

US$13.87As of Sun 8 Nov 2026, 12:00 UTC
NYSE:OGNHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (12.73%)
Div yield 0.58%
ROE 20.30%
Drug Manufacturers (General)
Beta (5Y) 1.49
PE TTM 17.14
TSR TTM 107.16%
Mkt cap US$3.643B
ROIC 6.10%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$18
26.31%
(73.23%)
Hold 5|5|6|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.15
0.14
15.92%
10.28%
5.82%
3.67%
Revenue$M
182.1
181.1
180.9
190.9
12.04%
8.66%
8.01%
7.94%
Peers (US$3.643B)
Cap (US$)
PE
36.71B
106.3x
3.974B
30.04x
Capital
TTM
5Y
10Y
Leveragex
0.321
0.028
0.044
EBIT/Intx
13.05
2.531
2.082
Own earn%
(639.34)
9.47
4.51
Sh yield%
44.16
44.16
41.27
Owners
Insiders/Inst%
14.49
30.03
Short interest%
4.85
SBC / revenue%
3.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–18
$1 testx
—
Incr. ROIC%
10